MHE State of the Industry survey: The shift to value-based care

MHE PublicationMHE December 2020
Volume 30
Issue 12

In this fifth part of a six-part series, data said respondents split on the effect of the pandemic on value-based care

Some see the COVID-19 pandemic as pushing American healthcare away from fee for service and into value-based care. The message from our State of the Industry survey is mixed. Almost half (46%) indicated that the pandemic had no effect on their organization’s relationship with value-based care and 9% said it had negative effect. On the other hand, 44% indicated some level of increase, including 5% who said it greatly increased value-based care.

Downside risk, which many see as essential to putting some cost-saving teeth into value-based care, still hasn’t taken hold, judging by our respondents. Two-thirds indicated that less than 25% of their value-based arrangements involved downside risk, and only 5% indicated that more than 50% of their value-based contracts involved downside risk."

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.